Jenny Shim, MD

Research Program

Cell and Molecular Biology
Phone Number

404-785-3240
Email Address

jenny.shim@emory.edu

Biography

Jenny Shim, is an instructor in the Department of Pediatrics at Emory University School of Medicine. Dr. Shim serves as a pediatric hematologist and oncologist at Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta.

Dr. Shim is a member of the Cell and Molecular Biology Research Program at Winship Cancer Institute of Emory University.

Education

Dr. Shim received her medical degree from Albany Medical College in Albany, New York. She completed her pediatric residency at The University of Texas Southwestern Medical Center in Dallas, Texas. She attended Emory University School of Medicine in Atlanta, Georgia, to complete her fellowship in pediatric hematology/oncology.

Titles & Roles

Instructor, Department of Pediatrics

Emory University School of Medicine

Research

Dr. Shim's current research interests center on improving our understanding of the genetics and tumor microenvironment of high-risk neuroblastoma, and identifying targetable therapeutic agents that will improve long-term survival. She is investigating the Yes-Associated Protein (YAP)/Hippo pathway in high-risk and recurrent neuroblastoma under the mentorship of Kelly Goldsmith, MD. She will be delineating the YAP/Hippo pathway and its role in high-risk and recurrent neuroblastomas to develop a novel targeted therapy in combination with other potential targeted therapies, such as MEK or Bcl-2 inhibitors.

Title/Journal	Authors	Publication Date
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin. Communications biology	K Mittal, GW Cooper, BP Lee, Y Su, KT Skinner, J Shim, HC Jonus, WJ Kim, M Doshi, D Almanza, BD Kynnap, AL Christie, X Yang, GS Cowley, BA Leeper, CL Morton, B Dwivedi, T Lawrence, M Rupji, P Keskula, S Meyer, CM Clinton, M Bhasin, BD Crompton, YY Tseng, JS Boehm, KL Ligon, DE Root, AJ Murphy, DM Weinstock, PC Gokhale, JM Spangle, MN Rivera, EA Mullen, K Stegmaier, KC Goldsmith, WC Hahn, AL Hong	08/04/2024
Early B-cell development and B-cell maturation are impaired in patients with active hemophagocytic lymphohistiocytosis. Blood	J Shim, S Park, S Venkateswaran, D Kumar, C Prince, V Parihar, L Maples, EK Waller, S Kugathasan, M Briones, M Lee, CJ Henry, S Prahalad, S Chandrakasan	07/12/2023
Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma. Cell reports. Medicine	JY Lee, HC Jonus, A Sadanand, GM Branella, V Maximov, S Suttapitugsakul, MJ Schniederjan, J Shim, A Ho, KK Parwani, A Fedanov, AA Pilgrim, JA Silva, RW Schnepp, CB Doering, R Wu, HT Spencer, KC Goldsmith	20/06/2023
The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1. Oncoimmunology	AA Pilgrim, HC Jonus, A Ho, AC Cole, J Shim, KC Goldsmith	01/01/2023